Introduction {#sec1-1}
============

Traumatic spinal cord injury (SCI) is a seriously debilitating disease with high mortality, and among survivors, a high degree of morbidity due to both motor and sensory deficit. Unfortunately, in spite of best efforts, little success has been achieved by any therapeutic modality in terms of neurological recovery.\[[@ref1]\] The available modalities for neurological recovery produce only minor improvements.

Despite a great deal of advancement in therapeutics, the life expectancy, prognosis, functionality, and quality of life remain poor in SCI patients with impaired neurological status. The recovery rate in SCI patients remains poor with any type of treatment because the neuronal cells, which are already in the highly differentiated stage, have negligible regenerative power. Several researchers have attempted the induction of controlled differentiation of the fully-modified brain cells to turn back as undifferentiated progenitors, either by using a differentiation-inducing agent\[[@ref2]\] or by stem cells application (trans-differentiation).\[[@ref3]\] We have already conducted a study in support of this for neurogenesis enhancement and axonal re-myelination using olfactory ensheathing cells under defined media.\[[@ref4]\] Further, our group had worked on ways to stimulate stem cells to regenerate neurons for functional recovery with promising results.

In SCI, the clinical application of embryonic, umbilical cord, adipose tissue, and bone marrow-derived mono-nuclear stem cells (BM-MNSCs) has been studied.\[[@ref5]\] The advantages of using BM-MNSCs are: first, one can minimize all problems associated with the immunological rejection which are frequently caused in allogenic cell transplantation,\[[@ref6]\] second, autologous cell infusion is considered safe by not being associated with carcinogenesis.\[[@ref7]\]

Earlier, we conducted a Phase I trial to determine the safety and efficacy of noncultured autologous BM-MNSCs in the management of acute SCI (ASCI), and their role in neurological recovery.\[[@ref8]\] There was a significant difference in percent mean recovery with stem cell application at the 12^th^ month of follow-up.

The current study was performed to evaluate the effect of BM-MNSCs as an adjuvant to conventional management of traumatic SCI for neurological recovery.

Materials and Methods {#sec1-2}
=====================

The current study, as Phase 2 trial, was conducted in the SCI Unit, Department of Orthopedic Surgery in collaboration with the Department of Transfusion Medicine, King George\'s Medical University (KGMU), Lucknow (UP), India from February 2013 to June 2016. This study was designed using the results of the Phase 1 randomized clinical trial on 110 ASCI participants to evaluate the safety and feasibility of application of BM-MNSCs and the role of surgery, omentoplasty and BM-MNSCs on clinical outcomes. Before this, the algorithm of aspiration, collection, isolation, and infusion of BM-MNSCs in SCI were standardized by us.\[[@ref9]\]

Study population {#sec2-1}
----------------

The target population participating in this study was from Northern India and Nepal.

Study design {#sec2-2}
------------

This is an open-label, individually randomized controlled, Phase II trial based on computer-generated random table (randomized controlled trial). As per random table, participants were randomized into three parallel groups \[[Supplementary Table 1](#T1){ref-type="table"}\].

###### 

Computer generated random number table

  Subject number   Groups   Random numbers
  ---------------- -------- ----------------
  1                2        0.379691597
  2                3        0.826511184
  3                2        0.626390294
  4                1        0.52476002
  5                2        0.38423567
  6                1        0.596431231
  7                2        0.363551065
  8                1        0.038267156
  9                2        0.243976593
  10               3        0.337591993
  11               3        0.922991656
  12               1        0.981388731
  13               3        0.880309098
  14               3        0.455295657
  15               2        0.650959411
  16               2        0.521302357
  17               3        0.856419611
  18               1        0.072280925
  19               2        0.116210275
  20               2        0.310114162
  21               2        0.715737802
  22               1        0.339025221
  23               3        0.22235138
  24               3        0.724534926
  25               3        0.442970448
  26               2        0.147874383
  27               3        0.033903279
  28               3        0.979011285
  29               3        0.16217519
  30               1        0.981780414
  31               3        0.775088438
  32               3        0.610992297
  33               1        0.637599785
  34               1        0.564163613
  35               1        0.74016944
  36               3        0.292297306
  37               1        0.120094748
  38               2        0.781976938
  39               1        0.387951285
  40               1        0.572985361
  41               2        0.347058089
  42               1        0.277429124
  43               2        0.518900366
  44               1        0.286803152
  45               2        0.520115372
  46               1        0.525508453
  47               1        0.59348895
  48               1        0.843203105
  49               3        0.20808
  50               1        0.904458204
  51               1        0.78062498
  52               3        0.831248384
  53               3        0.861647999
  54               2        0.344417904
  55               2        0.674902365
  56               3        0.994801921
  57               1        0.824338099
  58               2        0.75967438
  59               3        0.220128963
  60               1        0.218574498
  61               3        0.491022986
  62               3        0.658040752
  63               1        0.719478884
  64               1        0.137761463
  65               3        0.0490272
  66               3        0.396562856
  67               3        0.512734026
  68               3        0.113149317
  69               2        0.633816836
  70               2        0.463564631
  71               2        0.895262476
  72               1        0.602966628
  73               2        0.811485079
  74               3        0.944729554
  75               1        0.729150839
  76               2        0.022129039
  77               2        0.800427832
  78               3        0.020484784
  79               1        0.347439363
  80               2        0.013584913
  81               2        0.946513751
  82               3        0.144395366
  83               2        0.897122424
  84               2        0.29992265
  85               3        0.768663499
  86               1        0.448666161
  87               3        0.968265434
  88               3        0.562397966
  89               1        0.479438355
  90               2        0.560432281
  91               2        0.610297489
  92               1        0.486000972
  93               1        0.711688911
  94               2        0.889402243
  95               3        0.452224664
  96               1        0.740168457
  97               1        0.765864377
  98               3        0.675975322
  99               1        0.231078238
  100              2        0.860856493
  101              1        0.627745947
  102              2        0.784194508
  103              3        0.454721028
  104              3        0.615127956
  105              1        0.763861445
  106              3        0.531415144
  107              1        0.640770206
  108              1        0.522753706
  109              2        0.974808892
  110              1        0.519330807
  111              3        0.785856001
  112              1        0.892269363
  113              1        0.160209714
  114              2        0.883511449
  115              1        0.302554145
  116              2        0.620697894
  117              3        0.254555353
  118              1        0.348993761
  119              2        0.601861355
  120              2        0.033719411
  121              3        0.25806827
  122              2        0.881962391
  123              2        0.997635486
  124              2        0.074555961
  125              1        0.504423549
  126              1        0.936731586
  127              1        0.832966973
  128              2        0.045613097
  129              2        0.582627046
  130              3        0.413905064
  131              3        0.670844049
  132              3        0.110731028
  133              2        0.143868011
  134              1        0.541707503
  135              2        0.264096873
  136              3        0.384344029
  137              3        0.652926606
  138              2        0.727197548
  139              1        0.420559078
  140              1        0.456590187
  141              3        0.822688315
  142              1        0.49628237
  143              3        0.041932486
  144              2        0.445526725
  145              1        0.104513056
  146              1        0.486760096
  147              2        0.644425124
  148              2        0.41466249
  149              3        0.162011219
  150              3        0.141040177
  151              3        0.219040713
  152              2        0.147631247
  153              3        0.008752019
  154              3        0.591987509
  155              2        0.93616581
  156              1        0.102459597
  157              1        0.283961581
  158              3        0.809201759
  159              2        0.059533695
  160              3        0.851372108
  161              1        0.933543767
  162              3        0.224078755
  163              3        0.204600738
  164              2        0.278396763
  165              3        0.440816528
  166              2        0.752755481
  167              3        0.732375328
  168              2        0.852064425
  169              2        0.949470832
  170              1        0.159852727
  171              2        0.357160501
  172              3        0.5393509
  173              1        0.704169159
  174              3        0.062861198
  175              1        0.867120013
  176              3        0.018921388
  177              2        0.564542985
  178              2        0.310075636
  179              1        0.777801383
  180              2        0.814567661
  181              2        0.772694835
  182              1        0.352408732
  183              2        0.638175748
  184              2        0.856321592
  185              3        0.585713091
  186              2        0.87465694
  187              2        0.794606356
  188              1        0.230684358
  189              3        0.020600605
  190              1        0.645948846
  191              1        0.617203562
  192              3        0.155417885
  193              3        0.874684865
  194              2        0.475437254
  195              2        0.407702187
  196              2        0.577829604
  197              3        0.515830601
  198              3        0.146759892
  199              3        0.171817855
  200              1        0.606407918
  201              3        0.946249798
  202              2        0.27035361
  203              3        0.092812486
  204              1        0.998575296
  205              2        0.238553067
  206              1        0.026033118
  207              1        0.99545938
  208              1        0.534981311
  209              3        0.644973775
  210              3        0.989091339
  211              1        0.982432692
  212              1        0.63680991
  213              3        0.087602035
  214              1        0.644558885
  215              2        0.541237674
  216              1        0.489242512
  217              3        0.923200653
  218              2        0.398570752
  219              1        0.562082058
  220              2        0.240944539

Study groups {#sec2-3}
------------

Group 1 (Stem cell augmentation): ASCI participants managed by posterior instrumentation (titanium pedicle screw and rod devices) followed by infusion of autologous BM-derived stem cells as an adjuvantGroup 2 (Conventional): ASCI participants managed by posterior instrumentation (titanium pedicle screw and rod devices)Group 3 (Conservative): ASCI participants managed nonoperatively.

Sample size calculation {#sec2-4}
-----------------------

The sample size was calculated by using mean difference and standard deviation (SD) of recovery based on ASIA scores of Group 1 and Group 3 participants from Phase 1 trial. The mean difference and SD of stem cell augmentation group versus conservative group were 8.118 and 14.9, respectively. The level of significance was set at 5% (Z~α/2~=1.96) and the power of the study was 80% (Z~β~= 0.84). On adding 10% loss in follow-up, each group had 60 participants with a total of 180 participants for all the three groups.

Selection criteria of the participants {#sec2-5}
--------------------------------------

### Inclusion criteria {#sec3-1}

Participants of ASCI having complete lesion (ASIA Impairment Scale \[AIS\]-A grade) with thoracolumbar injury severity score (≥4) (unstable injury requiring stabilization by surgery)Thoracolumbar spine injury level between T4 and L2 vertebraAge between 18 and 65 years of either genderDuration of injury \<6 weeksSagittal continuity of the spinal cord and the presence of cord hemorrhage on MRI.

In MRI assessment of SCI, the axial and sagittal T2W images, and T2\*W GRE images are particularly useful. The most common injuries following cord trauma are edema, hemorrhage, and a mixture of both.\[[@ref10]\] Cord transaction patterns having worst prognosis are best predicted by the sagittal discontinuity of the spinal cord, whereas sagittal continuity provides a possibility of spinal cord containment within its sheath.\[[@ref11][@ref12]\]

### Exclusion criteria {#sec3-2}

Polytrauma patients with injury spine and associated thoraco-abdominal injuries and/or head injuryMedically unfit patients not suitable for surgeryPatients with other comorbid conditions such as osteoporosis, pressure sores (Grade III--IV), psychiatric illness and those on steroids or other immune suppressantsPatients who did not give their consent for participating in the study.

All enrolled participants were provided the standard surgical, medical as well as rehabilitation facilities. The assessment tool for recording the neurological status was the one proposed by the American Spinal Injury Association (ASIA). AIS grade, sensory, and motor scores were recorded at fixed time points after injury for neurological recovery. AIS Grade A, B, C, and D being nonparametric data were given numeric values such as 0, 1, 2, and 3, respectively, and then analyzed. In this study, we have documented neurological assessment at baseline and neurological recovery after 1 year \[[Supplementary Table 2](#T2){ref-type="table"}\].

###### 

Details of the participants

  Subjects      Age   Gender   MOI   Baseline   After 1 year   LOI   TLISS                        
  ------------- ----- -------- ----- ---------- -------------- ----- ------- ----- ---- --------- ---
  1             20    1        1     0          128            50    1       160   50   T12       7
  2             18    2        3     0          168            50    2       188   68   L1        8
  3             40    1        1     0          136            50    0       136   50   T6        6
  4             30    1        1     0          120            50    2       178   72   T8        6
  5             36    1        3     0          152            50    1       152   50   T12       7
  6             18    1        2     0          112            50    2       166   50   T8        6
  7             28    1        1     0          104            50    2       172   68   T6        7
  8             18    2        1     0          152            50    3       198   78   T12       7
  9             50    1        2     0          152            50    2       182   66   T4        7
  10            38    1        2     0          160            50    1       160   50   L1        6
  11            43    1        2     0          160            50    0       160   50   T8        6
  12            18    2        1     0          160            50    3       196   88   L1        8
  13            35    1        1     0          168            50    1       168   50   T12       6
  14            35    1        1     0          136            50    3       200   84   L1        6
  15            18    1        1     0          160            50    2       184   58   L1        8
  16            44    1        1     0          148            50    0       144   50   T9        6
  17            30    2        3     0          136            50    2       188   68   T11       6
  18            35    1        1     0          136            50    1       166   50   T12       6
  19            22    1        2     0          152            50    0       144   50   T7        7
  20            28    1        1     0          136            50    1       160   50   T8        9
  21            45    1        1     0          140            50    0       140   50   T5        7
  22            20    1        1     0          154            50    2       196   64   L1        6
  23            26    1        1     0          136            50    2       168   62   T10       6
  24            18    1        1     0          156            50    1       168   50   T7        6
  25            55    1        1     0          152            50    0       152   50   T12       8
  26            46    1        1     0          144            50    1       148   50   T9        6
  27            24    1        1     0          144            50    2       188   64   T12       6
  28            37    1        1     0          116            50    0       116   50   T6        8
  29            28    1        2     0          88             50    0       120   50   T7        6
  30            15    1        1     0          160            50    1       160   50   L1        6
  31            18    1        2     0          144            50    1       162   50   T10       6
  32            30    1        1     0          168            50    2       188   50   L2        7
  33            20    1        2     0          152            50    0       152   50   T5        9
  34            40    1        1     0          128            50    2       188   50   T10       7
  35            24    1        2     0          140            50    1       160   50   T10       6
  36            45    1        1     0          140            50    1       172   50   T9        6
  37            25    1        1     0          136            50    1       160   50   T10       6
  38            35    1        1     0          160            50    0       164   50   L1        8
  39            18    1        1     0          148            50    2       166   50   T10       6
  40            24    1        1     0          152            50    2       168   50   T11       6
  41            27    1        1     0          144            50    0       144   50   T10       8
  42            33    1        1     0          144            50    1       166   50   T11       6
  43            30    1        1     0          152            50    0       152   50   T9        6
  44            60    1        4     0          136            50    2       186   58   T10       6
  45            30    2        4     0          152            50    2       188   66   T12       7
  46            45    1        1     0          152            50    2       180   62   T12       9
  47            40    1        2     0          160            50    1       160   50   L1        7
  48            19    1        1     0          152            50    2       190   60   L1--2     6
  49            25    1        1     0          152            50    2       184   58   L1        6
  50            58    2        1     0          144            50    2       182   68   L1        8
  51            45    1        1     0          152            50    2       178   72   T12       6
  52            14    2        1     0          152            50    2       184   62   T12, L1   6
  53            22    1        1     0          128            50    1       176   50   T8        7
                                                                                                  
  **Group 1**                                                                                     
                                                                                                  
  54            25    1        1     0          128            50    0       144   50   T9        6
  55            30    1        1     0          128            50    1       168   54   T7--8     7
  56            35    1        2     0          144            50    0       144   50   T6        7
  57            35    1        1     0          152            50    3       196   76   T12       7
  58            32    1        1     0          144            50    0       144   50   T12       6
  59            45    1        2     0          152            50    2       180   58   L1        6
  60            25    1        1     0          124            50    2       182   62   T9        8
  61            22    1        1     0          160            50    1       168   50   L1        6
  62            22    1        1     0          144            50    1       182   64   T9--10    6
  63            35    1        3     0          128            50    2       188   68   T9        8
  64            22    1        1     0          144            50    2       186   58   L1        6
  65            30    1        1     0          160            50    2       184   56   T12       6
  66            35    1        1     0          144            50    2       190   50   T8        6
  67            27    1        1     0          136            50    1       164   50   T9--10    7
  68            30    1        1     0          144            50    1       160   50   T10--11   9
  69            40    1        1     0          136            50    2       174   64   T7        7
  70            24    1        1     0          160            50    3       192   66   L1        6
                                                                                                  
  **Group 2**                                                                                     
                                                                                                  
  1             26    1        1     0          152            50    0       152   50   T4        6
  2             30    1        1     0          136            50    2       154   62   T10       6
  3             12    1        1     0          160            50    2       174   64   L1        7
  4             34    1        3     0          128            50    0       128   50   T8        8
  5             22    1        1     0          104            50    1       120   54   T4--5     7
  6             15    2        1     0          160            50    2       174   68   L1        7
  7             40    1        1     0          144            50    0       144   50   T8--9     6
  8             35    1        3     0          148            50    2       168   62   T10--11   7
  9             30    1        1     0          168            50    0       168   50   T5        6
  10            29    1        2     0          108            50    0       108   50   T4--5     6
  11            35    1        1     0          152            50    1       166   54   T12--L1   7
  12            38    1        1     0          148            50    0       148   50   T10       6
  13            60    1        1     0          148            50    2       176   66   T10       6
  14            18    2        1     0          148            50    0       148   50   T6        6
  15            18    2        1     0          160            50    2       188   68   L1        6
  16            60    1        1     0          136            50    1       164   52   T10       6
  17            18    1        1     0          168            50    1       188   56   L2        6
  18            24    1        2     0          152            50    2       184   60   T12       5
  19            25    1        1     0          152            50    1       166   52   T12       6
  20            35    1        5     0          144            50    0       144   50   T9        5
  21            42    1        3     0          160            50    1       184   52   L1        6
  22            32    1        1     0          160            50    0       160   50   L1        7
  23            22    1        3     0          166            50    2       178   68   L2        7
  24            32    1        1     0          122            50    0       122   50   T4        6
  25            40    1        1     0          152            50    1       188   52   T12       6
  26            28    1        1     0          160            50    1       174   54   L1        6
  27            27    1        1     0          160            50    2       184   65   L1        7
  28            30    1        3     0          160            50    2       184   66   L2--3     8
  29            55    1        1     0          144            50    1       168   52   T10--11   7
  30            45    1        1     0          152            50    0       152   50   T9        6
  31            40    2        1     0          144            50    1       168   50   T11--12   7
  32            24    1        2     0          96             50    1       112   50   T4--5     6
  33            35    1        1     0          144            50    0       144   50   T9        6
  34            20    2        1     0          160            50    1       168   50   L2--3     7
  35            50    1        1     0          128            50    0       128   50   T9        6
                                                                                                  
  **Group 2**                                                                                     
                                                                                                  
  36            14    2        5     0          136            50    0       136   50   T4        6
  37            35    1        3     0          160            50    2       190   62   L1        6
  38            20    1        1     0          160            50    0       160   50   T5        6
  39            35    1        2     0          144            50    1       154   50   T11       6
  40            15    1        1     0          152            50    1       170   50   L1        6
  41            35    1        1     0          144            50    0       144   50   T11       5
  42            25    1        1     0          152            50    2       178   66   L1        6
  43            40    1        1     0          144            50    1       154   50   T12       5
  44            30    1        1     0          160            50    1       168   50   L1        6
  45            22    2        2     0          152            50    2       176   62   T12       7
  46            24    1        2     0          144            50    1       160   50   T11       7
  47            30    1        1     0          128            50    1       144   50   T8        6
  48            40    1        1     0          152            50    2       178   68   T12       6
  49            45    1        2     0          112            50    1       124   50   T7        6
  50            30    1        1     0          160            50    2       186   64   L1--2     7
  51            36    1        5     0          144            50    0       144   50   T10       7
  52            30    1        1     0          152            50    1       164   50   T12       6
  53            18    1        2     0          160            50    1       196   50   L1        6
  54            45    2        1     0          152            50    1       164   50   T12       6
  55            28    1        3     0          152            50    1       164   50   L1--2     6
  56            35    1        2     0          152            50    1       168   50   L1        6
  57            25    1        1     0          160            50    2       174   54   L1        6
  58            35    1        1     0          144            50    1       160   50   T11       6
  59            40    1        1     0          136            50    2       184   54   T7--8     6
  60            38    1        2     0          152            50    1       160   50   T12       7
  61            20    1        1     0          160            50    0       160   50   T11       6
  62            28    1        5     0          168            50    0       168   50   L2        7
  63            17    1        1     0          168            50    0       168   50   L2        6
  64            17    2        1     0          152            50    2       174   56   L1        6
  65            30    1        2     0          144            50    0       168   50   T7        6
  66            35    1        1     0          160            50    0       160   50   T12       5
  67            45    1        1     0          88             50    0       88    50   T5        7
  68            40    2        1     0          144            50    2       174   62   T12       7
                                                                                                  
  **Group 3**                                                                                     
                                                                                                  
  1             36    2        1     0          160            50    2       160   50   L1        6
  2             35    2        1     0          136            50    0       136   50   T9--10    6
  3             18    2        1     0          160            50    0       160   50   T6        7
  4             18    1        1     0          136            50    0       136   50   T10       6
  5             50    1        1     0          152            50    2       174   54   T12       7
  6             35    1        1     0          152            50    1       152   50   L1        7
  7             40    1        1     0          136            50    0       136   50   T10       7
  8             19    1        1     0          174            50    0       160   50   T12       6
  9             22    1        1     0          136            50    2       136   50   T5        6
  10            25    1        1     0          160            50    0       160   50   T12       8
  11            20    1        1     0          120            50    0       120   50   T10       6
  12            22    1        2     0          144            50    1       160   50   L1        6
  13            22    1        4     0          136            50    0       136   50   T10       8
  14            45    1        1     0          112            50    0       112   50   T11       6
  15            30    1        2     0          160            50    1       168   50   L1--2     6
  16            18    2        1     0          126            50    0       162   50   T6--7     6
  17            19    2        1     0          160            50    0       160   50   T10       7
                                                                                                  
  **Group 3**                                                                                     
                                                                                                  
  18            22    1        1     0          136            50    0       136   50   T12       9
  19            36    1        1     0          160            50    0       160   50   T12       7
  20            45    1        1     0          136            50    0       136   50   T10       6
  21            28    1        1     0          152            50    2       174   56   T12       7
  22            30    1        1     0          160            50    0       152   50   T8        7
  23            32    1        1     0          160            50    0       136   50   L1        6
  24            35    1        2     0          160            50    2       184   60   L2        6
  25            55    1        1     0          160            50    0       136   50   T10--11   6
  26            48    1        1     0          160            50    0       160   50   T6        6
  27            36    2        2     0          120            50    0       120   50   T10       6
  28            55    1        1     0          160            50    1       160   50   L1        6
  29            56    1        1     0          160            50    0       136   50   T12       6
  30            60    1        1     0          112            50    0       112   50   T7        6
  31            46    1        3     0          160            50    1       168   50   L1--2     7
  32            36    2        2     0          126            50    0       162   50   T6--7     6
  33            24    1        1     0          160            50    0       160   50   T6        7
  34            38    1        1     0          152            50    0       152   50   T12       6
  35            25    2        1     0          160            50    1       176   50   T10       6
  36            25    1        2     0          160            50    0       160   50   L1        6
  37            55    1        1     0          146            50    0       146   50   T11       5
  38            36    1        5     0          138            50    0       138   50   T10       7
  39            30    1        1     0          160            50    0       160   50   L1        7
  40            40    2        1     0          122            50    0       122   50   T8        7
  41            48    1        2     0          160            50    0       160   50   T7        8
  42            30    1        3     0          160            50    0       160   50   T11       6
  43            30    2        1     0          152            50    0       152   50   T12       6
  44            28    1        1     0          114            50    0       114   50   T7        7
  45            24    1        1     0          146            50    0       146   50   T11       6
  46            22    1        3     0          152            50    1       168   50   T11       7
  47            22    1        1     0          152            50    0       152   50   T12       7
  48            26    1        2     0          160            50    0       160   50   T7        7
  49            59    1        1     0          160            50    0       160   50   L1        6
  50            48    1        1     0          160            50    0       160   50   L1        6
  51            35    1        3     0          160            50    0       160   50   L1--2     8
  52            18    1        1     0          136            50    0       136   50   T8--9     6
  53            19    2        1     0          146            50    0       146   50   T11       6
  54            30    1        1     0          160            50    0       160   50   L1        8
  55            32    1        3     0          160            50    0       160   50   L2        6

Gender=1: Male, 2: Female, MOI=1: Fall from height, 2: Road traffic accident, 3: Weight over back, 4+5: Others, AIS grade=A: 0, B: 1, C: 2, D: 3, LOI = Level of injury, MOI=Mode of injury, TLISS = Thoraco-lumbar injury severity score, AIS = ASIA impairment scale, ASIA = American Spinal Injury Association

Intervention {#sec2-6}
------------

Participants in all the groups were managed for pressure offloading by turning and repositioning them every 2 h. The normal curvatures of the spine were maintained with the help of pillows, and care of bladder and bowel was ensured in participants suffering from incontinence. Routine investigations of fitness for surgery and anesthesia were done for surgical Groups 1 and 2. Standard operating procedures were used for instrumentation of pedicle screw and rods under fluoroscopic control. Distraction or compression was applied if required for reduction and stabilization of the fracture. Adequacy of the reduction was confirmed in anterior-posterior and lateral fluoroscopic views.

In addition, for Group 1 participants, aspiration, isolation, and purification of autologous BM-MNSCs were done as per algorithm described in our earlier study.\[[@ref9]\] BM aspiration was done for the preparation of stem cell concentrate required for autologous infusion. Approximately, 80--90 ml of autologous BM was aspirated from the posterior iliac crest and collected in primary CPDA bag of Quadruple CPDA-1 blood bag set. The crude BM was differentially centrifuged at 1200 rpm for 10 min at 10°C. The supernatant (plasma with nucleated cells) was transferred in one of the empty satellite bags of the quadruple set by using plasma expresser, making it rich in mononuclear cells along with leukocyte. It was then centrifuged at 2500 rpm for 10 min at 10°C and separated into a second empty satellite bag, leaving a precipitate (about 15 ml) of MNSCs in the first bag as a buffy coat. Approximately, 10 ml of precipitate was used for infusion and rest of the sample was sent for MNCs and CD34+ count which was found to have a mean count of 2.41 ± 1.198 × 10^6^ live cells.

After fixation of the spine, spinous process of the fractured vertebra was removed along with portion of the lamina to visualize ligamentum flavum, which was excised for exposing the spinal cord. The dura mater of the spinal cord was held carefully with plain forceps at two different points separated by 1 cm distance. A stab incision with a \#15 blade on a \#7 knife handle was made in the dura mater up to the depth of arachnoid matter. Epidural catheter was placed in the subarachnoid space at the site of the injured cord. The arachnoid was closed over the catheter with silk 3--0. Fascia and skin closure was done leaving the other end of the tip of the catheter outside the stitched wound. The catheter was connected to the infusion pump, through which autologous stem cells were infused at the rate of 1 ml/h. The infiltration of infusion sample was done under aseptic condition in the postoperative room. After complete infusion of the BM-MNSCs, the catheter was pulled out carefully ensuring the presence of the blue tip at the end of the catheter, which confirms complete removal of the catheter from the spinal cord.

After 48 h of surgery, in both the surgery groups, the SCI participants were mobilized on a wheelchair with anterior hyper-extension braces. Following removal of stitches, preferably on the 10^th^ day, the participants were transferred to the Department of Physical Medicine and Rehabilitation for structured rehabilitation protocol. The SCI participants of Group 3 were provided the same rehabilitation facilities as provided to both surgical groups. The facilities included early mobilization depending on neurological status, physiotherapy to facilitate recovery and prevention of known complications along with vocational training. The most common complications seen following ASCI were pressure sores, contractures, spasticity, bladder, bowel, and sexual dysfunction. SCI participants were followed-up in ortho outpatient department at 3-month interval for 1 year.

Statistical analysis {#sec2-7}
--------------------

Data of all the participants were collected at the time of admission (baseline) and after 1 year (as follow-up). Data were analyzed using statistical analysis software packages, namely, Statistical Package for Social Sciences (SPSS) version 16 (South Wacker Drive, Chicago, IL, USA). 0 and GraphPad. Paired *t*-test was used to compare AIS grades, motor, and sensory scores at baseline and follow-up in terms of mean and (mean ± SD) with 95% confidence interval (CI) at 5% level of significance. Groups were compared with each other using one-way analysis of variance with Bonferroni Correction *Post hoc* analysis to evaluate the mean difference, 95% CI and related *P* values of AIS grade, sensory, and motor scores after 1 year.

Desirable outcomes {#sec2-8}
------------------

BM-MNSCs augmentation improves neurological recovery in ASCI.

Statement of ethics {#sec2-9}
-------------------

This study was approved by the Ethics Committee (IEC 60^th^ ECM II-B/P14) and stem cell ethics committee (02/ISCES-12) of KGMU. The trial is registered under the Clinical Trial Registry of India (acknowledgment no. is REF/2017/08/015121). The study procedure was explained to all the participants in their native language. Written informed consent was also obtained from all the participants.

Results {#sec1-3}
=======

Participants were recruited as per inclusion criteria and divided into three groups according to the treatment plan. A total of 220 participants were enrolled for the study. Twenty-seven out of 220 participants could not complete the study either due to drop out in between the study or lost to follow-up. Finally, 193 participants who could be followed for a year were included. Group 1 had 70 participants who underwent conventional surgery along with BM-MNSCs as an adjuvant. In Group 2, there were 68 participants who were treated by conventional surgery and Group 3 included 55 participants who underwent nonoperative conservative therapy. The maximum drop out was seen in the conservative group because of the nonoperative treatment mode, in which participants were not willing for follow-up. As pretreatment record, the complete neurological assessment was done at baseline using AIS grading, sensory, and motor scores. After 1 year, the neurological assessment was again performed and compared with baseline values.

Demographic information {#sec2-10}
-----------------------

Majority of the participants were men, 166 individuals (86.01%) and 28 were female (13.99%). All the groups had male dominance (Groups 1, 2, and 3 had 90%, 85.29%, and 80% of male participants, respectively) \[[Table 1](#T3){ref-type="table"}\]. The age group of 18--30 years was most prone to SCI followed by other age groups. The mean age of Groups 1, 2, and 3 were 30.84 ± 10.56, 31.30 ± 9.74, and 33.42 ± 12.07 years, respectively \[[Table 2](#T4){ref-type="table"}\]. Fall from height (70.98%) and road traffic accident (16.58%) were the two most common modes of injury in our study. The group-wise distribution of age and mode of injury were almost the same in all the three groups \[[Table 1](#T3){ref-type="table"}\]. The mean ± SD of admission within 2 weeks for Groups 1, 2, and 3 were 3.61 ± 2.84, 4.7 ± 4.12, and 5.14 ± 3.84 with CI of 2.78--4.45, 3.26--6.14, and 3.62--6.66, respectively. Almost the similar trend was seen in groups whose participants were admitted between 2--4 and 5--6 weeks. The mean ± SD of management within 2 weeks of injury for Groups 1 and 2 were 6.07 ± 1.90 and 6.75 ± 2.63, respectively. Again, a similar trend was seen in participants of both the groups who were managed between 2--4 and 5--6 weeks of injury \[[Table 2](#T4){ref-type="table"}\].

###### 

General characteristics of subjects

                           Number of subjects                             
  ------------------------ -------------------- ------------ ------------ ------------
  Gender                                                                  
   Male                    166 (86.01)          63 (90)      58 (85.29)   44 (80)
   Female                  27 (13.99)           7 (10)       10 (14.7)    11 (20)
  Age group (years)                                                       
   18-30                   105 (54.4)           41 (58.57)   36 (52.94)   28 (50.9)
   31-45                   68 (35.23)           24 (34.29)   28 (41.18)   16 (29.09)
   46-60                   20 (10.36)           5 (7.14)     4 (5.88)     11 (20)
  Mode of injury                                                          
   Fall from height        137 (70.98)          52 (74.28)   46 (67.65)   39 (70.9)
   Road traffic accident   32 (16.58)           12 (17.14)   11 (16.18)   9 (16.36)
   Weight over back        16 (8.29)            4 (5.71)     7 (10.29)    5 (9.09)
   Others                  8 (4.14)             2 (2.85)     4 (5.88)     2 (3.64)
  Level of injury                                                         
   Level T4-T9             61 (31.61)           27 (38.57)   20 (29.41)   14 (25.45)
   Level T10-L2            132 (68.39)          43 (61.43)   48 (70.59)   41 (74.55)

Values are represented as frequency and percentage (%)

###### 

Duration between injury to hospitalization and injury to management

  Groups                                   Times        Mean±SD       P^a^        95% CI
  ---------------------------------------- ------------ ------------- ----------- -----------
  Group 1                                  \<2 weeks    3.61±2.84     \<0.001\*   2.78-4.45
  2-4 weeks                                16.36±3.78   14.54-18.19               
  5-6 weeks                                30.00±1.41   27.74-32.25               
  Group 2                                  \<2 weeks    4.70±4.12     \<0.001\*   3.26-6.14
  2-4 weeks                                17.48±4.14   15.96-19.00               
  5-6 weeks                                29.33±0.57   27.89-30.76               
  Group 3                                  \<2 weeks    5.14±3.84     \<0.001\*   3.62-6.66
  2-4 weeks                                18.50±4.29   16.59-20.40               
  5-6 weeks                                31.00±2.00   28.90-33.09               
                                                                                  
  **Duration between injury to surgery**                                          
                                                                                  
  Group 1                                  \<2 weeks    6.07±1.90     \<0.001\*   5.47-6.67
  2-4 weeks                                18.31±3.72   16.66-19.96               
  5-6 weeks                                31.28±1.70   29.70-32.86               
  Group 2                                  \<2 weeks    6.75±2.63     \<0.001\*   5.79-7.70
  2-4 weeks                                18.29±3.36   17.05-19.52               
  5-6 weeks                                30.40±1.51   28.51-32.28               

Values are represented as mean±SD. ^a^ANOVA, \*Significant. 95% CI = Confidence interval, SD =Standard deviation

ASIA Impairment Scale grade comparison {#sec2-11}
--------------------------------------

After 1 year of follow-up, improvements in sensory and motor abilities were observed in participants of all the groups, wherein the stem cell group showed the best results. In AIS grading, significant improvement was observed in Group 1 as compared to that of other groups. In Group 1, 21.43% of participants remained in AIS A, whereas the percentage improvement to AIS B, C, and D was 30%, 41.43%, and 7.14%, respectively, whereas in Group 2, the AIS A, B, C, and D values were 32.82%, 38.24%, 27.94%, and 0.0% and in Group 3, these were 78.18%, 12.73%, 9.09%, and 0.0%, respectively \[[Table 3](#T5){ref-type="table"}\].

###### 

American Spinal Injury Association impairment scale grades in different groups at baseline and 1 year

  Groups    ASIA grades                                                      
  --------- ------------- --- --- --- ------------ ------------ ------------ ----------
  Group 1   70 (100)      0   0   0   15 (21.43)   21 (30)      29 (41.43)   5 (7.14)
  Group 2   68 (100)      0   0   0   23 (33.82)   26 (38.24)   19 (27.94)   0
  Group 3   55 (100)      0   0   0   43 (78.18)   7 (12.73)    5 (9.09)     0

Values are represented as frequency and percentage (%). AIS-A = Complete (no sensory or motor function), AIS-B = Incomplete (sensory present but no motor function), AIS-C=Incomplete (motor function is also present), AIS = ASIA impairment scale, ASIA = American Spinal Injury Association

Baseline mean values for AIS grade, sensory and motor scores were 0 ± 0, 144.03 ± 14.91, and 50 ± 0, respectively, in Group 1. After 1 year, the mean values increased to 1.34 ± 0.9 (95% CI: 1.56--1.13), 169.34 ± 18.62 (95% CI: 30.08-20.55), and 58.83 ± 10.70 (95% CI: −11.38--−6.28), respectively, with *P* \< 0.001 for each of the above parameters. In "Group 2," baseline mean values for the above three parameters were 0 ± 0, 147.24 ± 16.56, 50 ± 0, and after 1 year were increased to 0.94 ± 0.79 (95% CI: 1.13--0.75), 160.82 ± 21.44 (95% CI:-16.44 to-10.73), and 54.28 ± 6.31 (95% CI:-5.81 to-2.75), respectively, with *P* \< 0.001 for each parameter. These data indicate that in all the three parameters, the AIS grades, sensory, and motor scores highly significant improvement was observed in both the surgery groups (stem cell augmentation group and conventional group). In "Group 3" (conservative, nonoperative group) baseline mean values were 0 ± 0, 148.33 ± 15.37, 50 ± 0, respectively, whereas, after 1 year values increased to 0.31 ± 0.63 (*P* = 0.0007, % CI: 0.48--0.14), 150.33 ± 16.87 (*P* = 0.19, % CI: 5.03--1.03), 51.60 ± 5.13 (*P* = 0.0245, 95% CI: −2.99--−0.21), respectively, and were highly significant in AIS grading only \[[Table 4](#T6){ref-type="table"}\].

###### 

Intra-group comparison of American Spinal Injury Association impairment scale grades, sensory, and motor scores at baseline and 1 year

  Groups                AIS (mean±SD)           *P*^a^                 Sensory (mean±SD)   *P*^a^         Motor (mean±SD)   *P*^a^                              
  --------------------- ----------------------- ---------------------- ------------------- -------------- ----------------- ---------- ---------- ------------- ----------
  Group 1               00±00                   1.34±0.90              0.0001\*            144.03±14.91   169.34±18.62      0.0001\*   50.00±00   58.83±10.70   0.0001\*
  95% CI - 1.56-−1.13   95% CI - 30.08-−20.55   95% CI - 11.38-−6.28                                                                                            
  Group 2               00±00                   0.94±0.79              0.0001\*            147.24±16.56   160.82±21.44      0.0001\*   50.00±00   54.28±6.31    0.0001\*
  95% CI - 1.13-−0.75   95% CI - 16.44-−10.73   95% CI - 5.81-−2.75                                                                                             
  Group 3               00±00                   0.31±0.63              0.0007\*            148.33±15.38   150.33±16.87      0.19       50.00±00   51.60±5.13    0.0245\*
  95% CI - 0.48-−0.14   95% CI - 5.03-1.03      95% CI - 2.99-−0.21                                                                                             

Values are represented as mean±SD. ^a^Paired *t*-test, \*Significant. 95% CI = Confidence interval, SD = Standard deviation, AIS = ASIA impairment scale, ASIA = American Spinal Injury Association

A *Post_hoc* analysis was performed for inter-group analysis to compare AIS grades, sensory, and motor scores in all the three groups (Group 1 vs. 2, 1 vs. 3, and 2 vs. 3) at baseline and after 1 year. The mean difference values for the AIS grade assessment were 0.40 (*P* = 0.010, 95% CI 0.075--0.727), 1.03 (*P* \< 0.001, 95% CI 0.688--1.378), and 0.63 (*P* \< 0.001, 95% CI 0.285--0.979) in Group 1 versus 2, 1 versus 3, and 2 versus 3, respectively. The mean difference values of sensory scores for treatment Group 1 versus 2, 1 versus 3, and 2 versus 3 were 8.52 (*P* = 0.030, 95% CI 0.619--16.419), 19.02 (*P* \< 0.001, 95% CI 10.285--27.375), and 10.49 (*P* = 0.009, 95% CI 2.082--18.910), respectively. Similarly, the mean difference values of motor scores were 4.55(*P* = 0.003, 95% CI 1.282--7.815), 7.22 (*P* \< 0.001, 95% CI −3.77--10.685), and 2.68 (*P* = 0.019, 95% CI −0.799--6.158), respectively \[[Table 5](#T7){ref-type="table"}\]. These results indicate Group 1 (stem cell augmentation) had statistically significant difference from Group 2 and 3 in all the three specified parameters.

###### 

Inter-group analysis of the American Spinal Injury Association impairment scale grading, sensory, and motor scores after 1 year

  Parameters    Groups comparision   Mean diffrence   P^a^            95% CI
  ------------- -------------------- ---------------- --------------- --------------
  AIS scoring   1 versus 2           0.40             0.010\*         0.075-0.727
  1 versus 3    1.03                 0.000\*          0.688-1.378     
  2 versus 3    0.63                 0.000\*          0.285-0.979     
  Sensory       1 versus 2           8.52             0.030\*         0.619-16.419
  1 versus 3    19.02                0.000\*          10.655-27.375   
  2 versus 3    10.49                0.009\*          2.082-18.910    
  Motor         1 versus 2           4.55             0.003\*         1.282-7.815
  1 versus 3    7.22                 0.000\*          3.771-10.685    
  2 versus 3    2.68                 0.193            −0.799-6.158    

^a^One-way ANOVA with Bonferroni correction, \*Significant. 95% CI = Confidence interval, AIS = ASIA impairment scale, ASIA = American Spinal Injury Association

Discussion {#sec1-4}
==========

Traumatic injury to the spinal cord immediately causes primary insult to the neural tissue, which remains irreversible and resistant to any intervention.\[[@ref13][@ref14][@ref15]\] After the primary injury, the inflammatory process gets activated and leads to secondary injury phase.\[[@ref16]\] The main hindrance in the process of neuronal regeneration is growth inhibitors present at the site of injury.\[[@ref17]\] Earlier studies were mostly focused on preventing and reducing the extent of secondary injury which may further damage the spinal cord.\[[@ref18][@ref19]\] An initial surgery is usually performed to provide support to damaged tissues and reduce the compression impact.\[[@ref20][@ref21]\] Surgery helps in spinal stabilization, preventing spinal deformity, and facilitating patient mobility but not in neurological recovery.\[[@ref22]\]

The available modalities for neurological recovery include the use of steroids and GM-1 ganglioside,\[[@ref19]\] functional electrical stimulation,\[[@ref23]\] retraining neural circuits to restore body functions, use of adaptive devices for communication, physical and occupational therapy, rehabilitation, and self-grooming techniques.\[[@ref24]\]

The repair of already damaged neurons may be initiated by stimulation of factors responsible for neuronal repair and regeneration. Studies have shown that stem cells can be stimulated to form new neurons, but their contribution to the healing process has not been supported by sufficient evidence.\[[@ref25]\] It has been observed by the studies that intrinsic adult stem cells and progenitor cells accumulate at the site of cord injury and help in neural tissue repair.\[[@ref26]\] Neural progenitor cells secrete neurotropic factors, triggering the growth of injured neurons.\[[@ref27]\] Stem cells make axons incapable of recognizing growth inhibitory molecules leading to axonal growth.\[[@ref13]\] Activities such as walking and sensory perception have shown marked improvement over time with stem cell therapy.\[[@ref14]\] Hematopoietic stem cells indirectly improve muscle strength and nerve regeneration,\[[@ref28][@ref29]\] whereas other studies suggested the use of granulocyte macrophage colony stimulating factor for the same.\[[@ref30]\]

This study was performed to evaluate the effect of BM-MNSCs, used as an adjuvant, to conventional management\[[@ref31]\] of traumatic SCI for neurological recovery. The results show that neurological recovery is better with stem cell augmentation in SCI surgery. According to the WHO, the global incidence of SCI is between 40 and 80 per million of population per year.\[[@ref32]\] The increasing incidences and persisting poor prognosis in neurological recovery cause despair in SCI participants and helplessness among physicians involved in their management.\[[@ref33]\] Unfortunately, no progress has been possible to reverse the primary injury caused to the spinal cord. Earlier studies were mostly focused on preventing and reducing the extent of the secondary injury and empowering people with SCI to return to an active and productive life. Researchers have been continually working on new treatments, including prostheses and medications that may promote nerve cell regeneration or improve the function of the nerves after ASCI.\[[@ref34]\]

In this study, the mean age of the participants was 31.74 years. The results indicate that youngsters are more prone to SCI. It may be because they are more active, courageous, and live an aggressive lifestyle. In contrast to participants from Western countries, the most common types of injuries in our study were fall from height (70.98%) followed by road traffic accidents (16.58%). This may be because in developing countries in rural areas, from where most of these participants arrive, fall from trees and uncovered roofs are common.\[[@ref35]\] This study was restricted to traumatic paraplegia participants only. Traumatic paraplegia is the result of damage to the cord at T2 level and below. To overcome the possibility of ascending edema following ASCI, in our study, participants of traumatic paraplegia having a complete lesion with the level of injury between T4 and L2 were included, to avoid any chance of SCI participants having quadriplegia. The most common vertebral level involved in our participants was between T10 and L2. Several studies have correlated "fall from height" with the injury of thoracolumbar junction (T10--L2).\[[@ref36]\]

Many studies have reported no significant improvement in SCI, if surgery is delayed by more than 3 weeks.\[[@ref37]\] In this study, the majority of participants were operated within 2 weeks of admission, but due to the late arrival of some participants, the duration between the injury to surgery reached up to 6 weeks. The participants reach late because in developing countries; besides lack of awareness, illiteracy, and poverty, there are misconceptions and superstitions, which hinder early-specialized health care services.\[[@ref38]\] Despite the late presentation of participants after injury, we have found significant improvement in the neurological recovery in all the groups. Participants operated within 2 weeks and those operated later had similar outcomes. Delay in surgery up to 6 weeks of injury did not affect recovery. In this study, we have used AIS grades to determine the severity of ASCI in participants. In comparison to the baseline information, there is an improvement in follow-up after 1 year. Group 1 shows maximum recovery, wherein 30% AIS Grade A achieved AIS Grade B, 41.43% Grade C, and 7.14% Grade D, which is quite remarkable. Group 2 shows recovery with 38.24% in AIS Grade B and 27.94% in Grade C. The reason for better recovery in Group 1 as compared to that of Group 2 could probably be attributed to stem cell augmentation, as this was the only factor that was different in the two groups. Group 3 also shows some recovery, but 78.18% of participants remained in the AIS grade A.

The recovery seen in the conservative group is due to spontaneous regeneration of neurons and is dependent on the physiology of participants. Various studies have shown that recovery in the conventional group is better than that in the conservative group because surgery provides stability to the spine and helps in the recovery of the injured spinal column. Surgery also reduces the possibility of further damage and arrests the secondary injury phase after ASCI.\[[@ref39]\] Decompressing the spinal cord further relieves the pressure on the cord and improves its vascularity. The recovery of participants in the conventional group was better as compared to those of conservative group, but was low as compared to that of the stem cell augmentation group. The plausible explanation for this is that the BM-MNSCs can repair the damaged area and may induce recovery by signals provided by the activators and inhibitors present at a particular niche of the damaged area. After infusion, BM-MNSCs also get converted into various types of cells (neurons, astrocytes, and oligodendrocytes) as per the requirement of the damaged site. Application of stem cells as an adjuvant at the site of injury provided the favorable environment for neurological recovery by attracting biochemicals required for the accelerated initiation, cell division, and differentiation of progenitor cells of peripheral blood into required cell types. At the same time, infused stem cells differentiate into neurons under the influence of existing biochemical environment caused by trauma.\[[@ref40]\]

AIS evaluation has been performed at two specific stages, first, at admission (pre-treatment) and the other after one year of follow-up. Mean values for AIS grade, sensory, and motor scores for Group 1 and Group 2 were 1.34, 169.34, 58.83 and 0.94, 160.82, and 54.28, respectively. A significant difference was found between both the groups with stem cell group showing better results in all the three parameters. Group 3 scores were almost similar to the baseline, which suggests a very small recovery. The results suggest that stem cells have a role in neurological recovery. Surgical methods are better than conservative treatment was also established by the scores and the AIS grades achieved after 1 year in all the groups.

Comparison among the groups was made to obtain mean difference values and *P* values of significance for AIS grade, sensory, and motor scores. The significant mean difference values of sensory scores were 8.52, 19.02, and 10.49, respectively, for all comparison groups (Group 1 vs. 2, 1 vs. 3, and 2 vs. 3). Group 1 had a statistically significant difference from Group 2 to 3 in all the three specified parameters. Group 2 also showed a statistically significant difference from Group 3 in some of parameters, but the result shown by participants of Group 1 versus 3 is not so robust.

Enumerating the strength of this study, it is based on our pilot study in which participants of ASCI were treated with stem cells. This study had standard outcome measures with clear documentation and data management to ensure reproducibility. A properly matched baseline characteristics in all the participants minimized confounders. The maximum participation of participants throughout the follow-up period was ensured by staying in touch with them and their attendants, either by phone or through home visits. Finally, participants participating in this study represented a large geographical area to minimize the regional variation bias, and to ensure that the results will be representative of the population studied. The limitations of this study were the exclusion of SCI cases having tetraplegia (cervical and cervicothoracic lesions), SCI \>6-week-old, the inclusion of AIS A participants only (complete lesions) and the concern of spontaneous recovery seen in SCI which may lead to clinician\'s bias in interpretation of results. Then, although we have infused 2.41 ± 1.198 × 10^6^ (mean count) of live stem cells, but did not correlate them individually with the recovery. It was because of ethical reasons that we could not take the BM from conventional and conservative group participants for stem cell count. Furthermore, at the end of follow-up, the number of participants in each group was unequal and the conservative group had the least number of participants. This group had a general thought that, as they were not operated, there was not much need of regular follow-up. Nonetheless, fortunately, the numbers of participants in both the surgery groups were more than the required sample size of 60 in each group and only five short (55) in the conservative group.

Conclusions {#sec1-5}
===========

This study concluded that the conventional treatment by surgery to stabilize the unstable spine gave better results over conservative treatment. The results of delayed surgery by up to 6 weeks were comparable with those of early surgery. The synergistic use of stem cells as an adjuvant with conventional treatment showed the best recovery results among all the specified groups and ultimately stresses on the significant role of BM-MNSCs in SCI. Application of stem cells as an adjuvant at the site of injury provided the favorable environment and the precursors for neurological recovery.
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